Resilience Curriculum for Novice Physicians-in-training

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04977726
Collaborator
Western University (Other)
24
2
10

Study Details

Study Description

Brief Summary

To determine the feasibility of delivering a structured resilience curriculum to novice physicians-in-training, we propose a pilot study to evaluate recruitment rates, course attendance and compliance with follow-up surveys. If our study can demonstrate feasibility in course delivery, further engagement of postgraduate specialty programs will facilitate conduct of an appropriately powered randomised controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: STRIVE curriculum
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Resilience Curriculum for Novice Physicians-in-training: a Randomized Controlled, Feasibility Trial.
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: STRIVE - Simulation Training for Resilience in Various Environments

Behavioral: STRIVE curriculum
STRIVE is adapted from the Road to Mental Readiness curriculum, developed by the Department of National Defence in Canada. It is comprised of a 4-hour formal education session where participants are provided knowledge, skills and resources specific to self-assessment for mental wellness and effective mindfulness strategies. High fidelity simulation sessions are then utilized to reinforce and apply mindfulness techniques learned in the formal session.

Sham Comparator: Control

Behavioral: STRIVE curriculum
STRIVE is adapted from the Road to Mental Readiness curriculum, developed by the Department of National Defence in Canada. It is comprised of a 4-hour formal education session where participants are provided knowledge, skills and resources specific to self-assessment for mental wellness and effective mindfulness strategies. High fidelity simulation sessions are then utilized to reinforce and apply mindfulness techniques learned in the formal session.

Outcome Measures

Primary Outcome Measures

  1. Participant Recruitment Potential [9 months]

  2. STRIVE Course Completion [9 months]

    Number of participants randomized to the intervention that complete the STRIVE course

  3. Follow-up Survey Compliance [9 months]

Other Outcome Measures

  1. Self-Reported Resilience at 3 months [9 months]

    Connor-Davidson Resilience Scale (CD-RISC 10). This is a briefer, 10 item version of the full Connor-Davidson Resilience Scale. The scale is 0 to 40 with a higher number representing higher resilience. This scale has been validated in a variety of populations and is a widely used research tool to assess resilience.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All first and second year medical residents enrolled in the Schulich School of Medicine & Dentistry Anesthesia & Emergency Medicine postgraduate residency programs.
Exclusion Criteria:
  • None

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Lawson Health Research Institute
  • Western University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sonja Payne, Assistant Professor, Consultant Anesthesiologist, Principal Investigator, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT04977726
Other Study ID Numbers:
  • 11098
First Posted:
Jul 27, 2021
Last Update Posted:
Jul 30, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jul 30, 2021